The abstract is read at the publisher; the summary is JClub's.
Earlier 3-month viral load testing and longer visit intervals after South Africa’s 2023 ART guideline change increased uptake, while viral suppression at first testing stayed at 72% for both 3- and 6-month windows.
- Why it matters: The revision aimed to speed differentiation and monitoring, but real-world uptake and whether longer intervals affect virologic outcomes were unclear in routine primary care.
- What they did: Using electronic medical records from 18 primary healthcare clinics across three South African districts (N=16,338; Jan 2022–Mar 2025), interrupted time series assessed uptake after April 2023, and modified Poisson regression estimated relative risks for viral suppression at first and second routine VL tests.
- The result: First VL testing occurred in 27% at 3 months and 30% at 6 months, with 3-month coverage rising to 72–85% and 6-month visit intervals reaching 48–71%; viral suppression was 72% at first VL for both windows, and longer intervals were not linked to subsequent suppression (aRR 1.02, 95% CI 0.99–1.06).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.